Editorial comment

Urology. 2011 Jan;77(1):129-30; author reply 130. doi: 10.1016/j.urology.2010.07.509.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Humans
  • Male
  • Phosphodiesterase 5 Inhibitors / therapeutic use*
  • Prostatic Hyperplasia / complications*
  • Prostatism / drug therapy*
  • Prostatism / etiology*

Substances

  • Phosphodiesterase 5 Inhibitors